Cargando…
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease
Current research efforts are focused on the application of growth factors, such as glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), as neuroregenerative approaches that will prevent the neurodegenerative process in Parkinson’s disease. Continuing a pr...
Autores principales: | Herrán, Enara, Requejo, Catalina, Ruiz-Ortega, Jose Angel, Aristieta, Asier, Igartua, Manoli, Bengoetxea, Harkaitz, Ugedo, Luisa, Pedraz, Jose Luis, Lafuente, Jose Vicente, Hernández, Rosa Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043720/ https://www.ncbi.nlm.nih.gov/pubmed/24920904 http://dx.doi.org/10.2147/IJN.S61940 |
Ejemplares similares
-
The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
por: Vegas‐Suárez, Sergio, et al.
Publicado: (2021) -
6‐Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata
por: Vegas‐Suárez, Sergio, et al.
Publicado: (2020) -
Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases
por: Hernando, Sara, et al.
Publicado: (2020) -
Antiparkinson Prodrugs
por: Di Stefano, Antonio, et al.
Publicado: (2008) -
Endocannabinoid Modulation of Dopaminergic Motor Circuits
por: Morera-Herreras, Teresa, et al.
Publicado: (2012)